| Literature DB >> 29768694 |
Hazrat Belal1, Mitsuko Nakashima1,2, Hiroshi Matsumoto3, Kenji Yokochi4,5, Mariko Taniguchi-Ikeda6,7, Kazushi Aoto1, Mohammed Badrul Amin1,8, Azusa Maruyama9, Hiroaki Nagase6, Takeshi Mizuguchi2, Satoko Miyatake2, Noriko Miyake2, Kazumoto Iijima6, Shigeaki Nonoyama3, Naomichi Matsumoto2, Hirotomo Saitsu1.
Abstract
By whole exome sequencing, we identified three de novo RHOBTB2 variants in three patients with epileptic encephalopathies (EEs). Interestingly, all three patients showed acute encephalopathy (febrile status epilepticus), with magnetic resonance imaging revealing hemisphere swelling or reduced diffusion in various brain regions. RHOBTB2 encodes Rho-related BTB domain-containing protein 2, an atypical Rho GTPase that is a substrate-specific adaptor or itself is a substrate for the Cullin-3 (CUL3)-based ubiquitin ligase complex. Transient expression experiments in Neuro-2a cells revealed that mutant RHOBTB2 was more abundant than wild-type RHOBTB2. Coexpression of CUL3 with RHOBTB2 decreased the level of wild-type RHOBTB2 but not the level of any of the three mutants, indicating impaired CUL3 complex-dependent degradation of the three mutants. These data indicate that RHOBTB2 variants are a rare genetic cause of EEs, in which acute encephalopathy might be a characteristic feature, and that precise regulation of RHOBTB2 levels is essential for normal brain function.Entities:
Keywords: CUL3; RHOBTB2; acute encephalopathy; epileptic encephalopathy; proteasomal degradation
Mesh:
Substances:
Year: 2018 PMID: 29768694 DOI: 10.1002/humu.23550
Source DB: PubMed Journal: Hum Mutat ISSN: 1059-7794 Impact factor: 4.878